22.28
수혈은 생명을 구하고 다양한 의학적 상태를 치료하는 중요한 의료 절차입니다. 여기에는 헌혈자로부터 수혈인에게 혈액을 옮기는 것이 포함됩니다. 이 과정에는 ABO 혈액형 시스템과 관련 항원 및 항체에 대한 철저한 이해가 필요합니다.
수혈 개요
수혈은 부상, 수술로 인해…
수혈은 부상, 수술 또는 빈혈이나 암과 같은 질환에 대한 치료로 인해 손실된 전혈 또는 그 구성 요소를 대체하는 의료 절차입니다.
성공적인 수혈을 위해서는 헌혈자와 수혈자의 혈액이 항원-항체 반응을 피할 수 있도록 호환되어야 합니다.
이러한 호환성은 일반적으로 ABO 혈액형 시스템을 사용하여 결정됩니다.
예를 들어, A형 환자가 B형 기증자로부터 혈액을 투여받으면 수혜자의 항B 항체가 기증자의 세포에 있는 B 항원과 반응하여 응집과 용혈을 일으킵니다.
O형 혈액을 가진 개인은 A 또는 B 항원이 부족하여 이론적으로 O 혈액형을 보편적인 기증자 그룹으로 만듭니다.
반대로, AB 혈액형을 가진 개인은 A 또는 B 항원에 대한 항체가 없기 때문에 보편적인 수혜자로 간주됩니다.
그러나 ABO 시스템을 기반으로 하는 보편적 수혜자와 기증자의 임상적 적용은 Rh 계열과 같이 ABO 항원 이외의 다른 자연 발생 항원으로 인해 위험할 수 있습니다.
따라서 수혈 합병증을 피하기 위해 정확하게 일치하는 혈액형을 사용하는 것이 가장 좋습니다.
View the full transcript and gain access to JoVE Core videos
Q1: Why is blood type compatibility important for transfusions?
Blood type compatibility prevents dangerous antigen-antibody reactions. If a recipient receives incompatible blood, their antibodies attack the donor's red blood cells, causing agglutination and hemolysis. For example, a type A patient receiving type B blood triggers anti-B antibodies to react with B antigens on donor cells. Matching blood types ensures safe transfusion and protects patient health.
Q2: What makes type O blood a universal donor?
Type O blood lacks both A and B antigens on red blood cell surfaces. Since these antigens are absent, type O blood does not trigger antibody reactions in any recipient's bloodstream, regardless of their blood type. This absence of major ABO antigens makes type O the universal donor, though screening for other blood group systems remains important for safe transfusion.
Q3: How do AB blood type individuals serve as universal recipients?
Individuals with AB blood type lack antibodies against A and B antigens. Since they produce neither anti-A nor anti-B antibodies, their immune system does not attack donor red blood cells carrying these antigens. This allows AB recipients to safely receive blood from any ABO blood type without antibody-mediated agglutination or hemolysis.
Q4: What happens when agglutination occurs during a transfusion?
Agglutination is the clumping of red blood cells that occurs when a recipient's antibodies bind to incompatible donor antigens. This clumping can block blood vessels and trigger hemolysis, where red blood cells rupture and release hemoglobin into the bloodstream. Agglutination represents a serious transfusion reaction that can cause organ damage and life-threatening complications if incompatible blood is transfused.
Q5: Why is screening necessary beyond the ABO blood group system?
Although the ABO system classifies blood types, other naturally occurring antigens exist beyond A and B, such as the Rh family. Relying solely on universal donor and recipient concepts based on ABO can be risky because these other blood group systems may cause incompatibility reactions. Medical professionals conduct screening using soluble ABO antigens in bodily fluids or peripheral blood samples to identify all potential incompatibilities and prevent serious adverse reactions.
Q6: What medical conditions require blood transfusions?
Blood transfusions replace blood lost due to injury or surgery and treat conditions like anemia and cancer. Anemia reduces oxygen-carrying capacity, while cancer treatments may damage bone marrow's ability to produce red blood cells. Transfusions restore blood volume and oxygen delivery to tissues, supporting recovery and improving patient outcomes in these critical medical situations.
Q7: How does the ABO system classify blood types?
The ABO system classifies blood into four types based on the presence or absence of A and B antigens on red blood cell surfaces. Type A has A antigens, type B has B antigens, type AB has both, and type O has neither. Each blood type also produces specific antibodies: type A produces anti-B antibodies, type B produces anti-A antibodies, type AB produces neither, and type O produces both anti-A and anti-B antibodies.